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REPLY
We appreciate Dr. Budoff’s interest in our paper on C-reactive
protein and calcium in postmenopausal women. The hypothesis
tested in our study (1) was whether postmenopausal women
enrolled in the Females, Lipids, Activity and Sex Hormones
(FLASH) study with coronary calcium by electron beam computed
tomography (EBCT) would have higher concentrations of high
sensitivity testing for C-reactive protein (hsCRP), an inflamma-
tory marker believed to be an independent risk factor for cardio-
vascular disease (2). However, we found no evidence of a positive
association of hsCRP and calcium by EBCT. We suggested that
hsCRP may be a marker for inflammation and EBCT may be a
marker for mature and more stable atherosclerotic plaque. We also
stated that these data highlight the importance of careful prospec-
tive clinical evaluation of emerging technologies such as EBCT,
the same conclusion reached by the recent American College of
Cardiology/American Heart Association (ACC/AHA) Expert
Consensus panel on EBCT (3).
Dr. Budoff takes issue with our statement that “individuals with
normal EBCT scores may nonetheless suffer MI.” However, this
statement is supported by the data not only in the paper referenced,
but also in papers by Secci (4) (ref. 27 in the paper), Arad (5) (ref.
14 in the paper), South Bay Heart Watch (6) (ref. 28 in the paper),
Raggi (7), and by the recent ACC/AHA statement (3).
In addition, Dr. Budoff states that “the question answered in the
paper is that not every asymptomatic person with atherosclerosis
has inflammation, which was known from the CARE study.”
However, as the CARE study exclusively studied patients after
myocardial infarction, it did not provide any information about
asymptomatic persons. Similarly, the FLASH study patients were
all asymptomatic, but many did not have atherosclerosis. Thus, his
interpretation of these papers is inconsistent with their study
designs.
Finally, the CARE study did not measure EBCT scores. Hence,
Dr. Budoff’s statement that the CARE study (8) showed that the
“combination [calcium scores and hsCRP levels] more strongly
predicts future events” is incorrect. However, we agree with Dr.
Budoff that this is an important hypothesis to test.
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